MedPath

ASAN FOUNDATION

ASAN FOUNDATION logo
🇰🇷South Korea
Ownership
Private
Established
1989-06-23
Employees
501
Market Cap
-
Website
https://ails.amc.seoul.kr

Strategy to Improve Adherence of Roflumilast

Phase 4
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
First Posted Date
2013-12-23
Last Posted Date
2013-12-23
Lead Sponsor
Asan Medical Center
Target Recruit Count
80
Registration Number
NCT02018432
Locations
🇰🇷

Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents

Phase 1
Conditions
Non-malignant Disease
Haploidentical Hematopoietic Stem Cell Transplantation
Malignant Disease
Interventions
Biological: anti-thymocyte globulin
Biological: filgrastim
Radiation: Total body irradiation
Procedure: TCRαβ-depleted hematopoietic cell transplantation
Device: CliniMACS
First Posted Date
2013-12-18
Last Posted Date
2017-03-28
Lead Sponsor
Asan Medical Center
Target Recruit Count
30
Registration Number
NCT02014506
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Drug: FEC3-D3
First Posted Date
2013-12-05
Last Posted Date
2017-08-29
Lead Sponsor
Asan Medical Center
Target Recruit Count
250
Registration Number
NCT02001506
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Drug: AC4-CDDP4
First Posted Date
2013-12-05
Last Posted Date
2014-12-02
Lead Sponsor
Asan Medical Center
Target Recruit Count
88
Registration Number
NCT02001519
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer

Phase 3
Completed
Conditions
Recurrent Breast Cancer
Stage IV Breast Cancer
Interventions
Drug: [18F]fluoroestradiol (FES)
First Posted Date
2013-11-18
Last Posted Date
2016-12-08
Lead Sponsor
Asan Medical Center
Target Recruit Count
93
Registration Number
NCT01986569
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome

Completed
Conditions
Interstitial Cystitis
First Posted Date
2013-11-15
Last Posted Date
2019-07-05
Lead Sponsor
Asan Medical Center
Target Recruit Count
67
Registration Number
NCT01985880
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

🇰🇷

Asan medical center Institutional review board, Seoul, Korea, Republic of

Vaccination Status, Knowledge and Attitude in Korean Patients With IBD

Completed
Conditions
Inflammatory Bowel Disease
Interventions
Other: Survey with structured questionnaire form for inflammatory bowel disease patient group
First Posted Date
2013-11-15
Last Posted Date
2022-12-28
Lead Sponsor
Asan Medical Center
Target Recruit Count
287
Registration Number
NCT01984879
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients

Phase 3
Conditions
Liver Transplant Recipient
Interventions
First Posted Date
2013-11-01
Last Posted Date
2013-11-01
Lead Sponsor
Asan Medical Center
Target Recruit Count
172
Registration Number
NCT01974375
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy

Phase 2
Completed
Conditions
Central Serous Chorioretinopathy
Interventions
Drug: Sham injection
Procedure: Half-fluence photodynamic therapy
First Posted Date
2013-10-29
Last Posted Date
2015-06-25
Lead Sponsor
Asan Medical Center
Target Recruit Count
43
Registration Number
NCT01971190
Locations
🇰🇷

Chungbuk national hospital, ChungJu, Korea, Republic of

🇰🇷

Gangneung asan hospital, Gangneung, Korea, Republic of

🇰🇷

Seoul national university Bundang Hospital, Ilsan, Korea, Republic of

and more 3 locations

[18F]Fluciclatide PET Imaging of Pazopanib Response

Phase 2
Terminated
Conditions
Kidney Neoplasm
Interventions
First Posted Date
2013-10-11
Last Posted Date
2016-03-01
Lead Sponsor
Asan Medical Center
Target Recruit Count
12
Registration Number
NCT01961583
Locations
🇰🇷

Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath